MIRM
NASDAQ · Biotechnology
Mirum Pharmaceuticals Inc
$94.51
-11.28 (-10.66%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-6.00%
1Y
+57.99%
YTD
+21.06%
Open$90.25
Previous Close$105.79
Day High$97.00
Day Low$88.88
52W High$130.00
52W Low$50.25
Volume—
Avg Volume591.1K
Market Cap6.46B
P/E Ratio—
EPS$-13.60
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$87.61
Above
SMA 200
$68.12
Above
RSI (14)
56.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
20 analysts
Price Target
-29.4% upside
Current
$94.51
$94.51
Target
$66.73
$66.73
$36.90
$66.73 avg
$76.87
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 633.30M | 334.85M | 354.29M |
| Net Income | -28,380,663 | -13,505,312 | 95.30M |
| Profit Margin | -4.5% | -4.3% | 26.9% |
| EBITDA | 2.56M | 1.29M | 155.69M |
| Free Cash Flow | — | — | 58.63M |
| Rev Growth | +89.1% | +89.1% | +17.5% |
| Debt/Equity | 0.98 | 0.98 | 0.71 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $245.22 | +0.55% | 122.9 | 446.67B |
| AMGN | Amgen Inc | $407.95 | +0.77% | 26.5 | 206.48B |
| GILD | Gilead Sciences Inc | $133.75 | +2.21% | 17.6 | 161.72B |
| VRTX | Vertex Pharmaceuticals Inc | $484.53 | -0.06% | 27.8 | 120.52B |
| REGN | Regeneron Pharmaceuticals | $782.10 | +1.29% | 17.5 | 77.36B |
| ALNY | Alnylam Pharmaceuticals Inc | $217.68 | +0.72% | 47.7 | 27.52B |